AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/coms2/summary_0286-24307906_ITM" title="Facts and information about FDA approves Valtrex caplets for reducing risk of spreading genital herpes.">FDA approves Valtrex caplets for reducing risk of spreading genital herpes.</a>

Close Set up an RSS feed that alerts you when new articles from Asia Africa Intelligence Wire are available.

Frequently asked questions about RSS feeds

FDA approves Valtrex caplets for reducing risk of spreading genital herpes.

Asia Africa Intelligence Wire

| August 29, 2003 | COPYRIGHT 2003 Financial Times Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

(From Chemical Business NewsBase - Press Release)

GlaxoSmithKline (GSK) announced that the US Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for Valtrex (valacyclovir HCl) caplets for suppressive therapy in otherwise healthy adults with genital herpes in order to reduce the risk of heterosexual transmission of genital herpes. The study of 1484 couples conducted in support of the application showed that once-daily…

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


Press Release: AuRx Inc announces publication of the successful results of the...: News wire article from: Asia Africa Intelligence Wire October 11, 2002 700+ words
(From Chemical Business NewsBase: Press Release...therapeutic vaccine for genital herpes has published the...trial for treatment of genital herpes in the Oct 2002 issue...of the treatment of genital herpes, the AuRx therapeutic...


GlaxoSmithKline (GSK) to conduct genital herpes vaccine trial on women in the...: News wire article from: Asia Africa Intelligence Wire December 16, 2002 700+ words
(From Chemical Business NewsBase - Pharma Japan) A large Phase III clinical trial of a novel prophylactic genital herpes candidate vaccine is to be conducted in the US by GlaxoSmithKline Biologicals, Belgium, and the US National Institute of...


New study evaluates the effectiveness of Valtrex caplets for suppression of...: News wire article from: Asia Africa Intelligence Wire October 25, 2002 700+ words
(From Chemical Business NewsBase - Press Release) Twice...caplets is effective in suppressing genital herpes recurrences in HIV-infected patients...experienced a delay in the time to first genital herpes recurrence as well as a delay in...


Landmark survey reveals new INSIGHTS into genital herpes; Novartis announces...: News wire article from: Asia Africa Intelligence Wire March 5, 2003 700+ words
(From Chemical Business NewsBase - Press Release...information about genital herpes in order to better...being diagnosed with genital herpes including how it would...respondents said that genital herpes affected their sex...


FDA approves Valtrex Caplets for suppression of recurrent genital herpes in...: News wire article from: Asia Africa Intelligence Wire April 2, 2003 700+ words
(From Chemical Business NewsBase - Press Release...suppression of recurrent genital herpes in HIV-infected...suppression of recurrent genital herpes outbreaks in HIV...history of recurrent genital herpes, in addition to HIV...


Valaciclovir effective against genital herpes.: News wire article from: Chemical Business Newsbase October 30, 2006 700+ words
(From Chemical Business NewsBase - Pharma Japan...inhibiting the recurrence of genital herpes. Valaciclovir is marketed...valaciclovir in treatment of genital herpes recurrence. Some 72...treated annually for genital herpes in Japan.


Successful clinical trial results for AuRx genital herpes therapeutic vaccine...: News wire article from: Asia Africa Intelligence Wire November 20, 2002 700+ words
(From Chemical Business NewsBase - Press Release...vaccine for treatment of genital herpes at the Eugene Bereston...symptoms of recurrent genital herpes in 43.5% of the...rate for episodes of genital herpes was reduced 84% from...


US clinical trial of VivaGel for genital herpes commences.: News wire article from: Chemical Business Newsbase October 24, 2006 700+ words
(From Chemical Business NewsBase - Press Release...for prevention of genital herpes has opened for recruitment...for prevention of genital herpes had successfully completed...with prevention of genital herpes as the indication...


IND for clinical development of VivaGel for genital herpes prevention clears US...: News wire article from: Chemical Business Newsbase July 19, 2006 700+ words
(From Chemical Business NewsBase - Press Release...the prevention of genital herpes has successfully completed...the prevention of genital herpes to be funded by the...with prevention of genital herpes as the indication...


NIH funds clinical development of VivaGel for genital herpes.: News wire article from: Chemical Business Newsbase April 19, 2006 700+ words
(From Chemical Business NewsBase - Press Release...VivaGel in the prevention of genital herpes. Genital herpes is the second indication for...for VivaGel for prevention of genital herpes with the US Food and Drug Administration...

For more facts and information, see all results

The AccessMyLibrary advertising network includes: